Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02389075 · ClinicalTrials.gov registry record

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

A clinical trial of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD), sponsored by University of Colorado, Denver.

Active
Registry status
129
Enrollment target
1
Study location

NCT02389075 is a study of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD) that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 129 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02389075, a study of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD), is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
129 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.

Interventions

  • PROCEDURE Pinch biopsies
  • PROCEDURE Flexible sigmoidoscopy

Study Locations (1)

Colorado

  • University of Colorado - Denver

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2015-03
Est. Completion 2026-10

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02389075

The ClinicalTrials.gov registry entry for NCT02389075 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ankylosing Spondylitis (AS) appearing as the primary indexed condition, and to 2 interventions - of which Pinch biopsies is the first listed.

NCT02389075 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02389075 about?

NCT02389075 is a clinical study titled "The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis". This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.

What is the current status of trial NCT02389075?

This trial is currently active not recruiting. The enrollment target is 129 participants. The study started on 2015-03. Estimated completion is 2026-10.

What conditions does trial NCT02389075 study?

This clinical trial studies the following conditions: Ankylosing Spondylitis (AS), Inflammatory Bowel Diseases (IBD).

What interventions are being tested in trial NCT02389075?

The interventions under investigation include: Pinch biopsies (PROCEDURE), Flexible sigmoidoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT02389075?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02389075 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ankylosing Spondylitis (AS)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.